Reports

Industry Research Reports

Home > Reports > Service & Software > Global Plasma Fractionation Technology Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Plasma Fractionation Technology Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Plasma Fractionation Technology Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Service & Software

Published Date: 2025-11-17

Pages: 105 Pages

Report ld: 5479001

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Plasma Fractionation Technology Market Size(US$)

den_QYR1
cagr

CAGR 2025-2031

7.5%

marketSize

Market Size,2031

USD 58,200

Million

Market Snapshot

Market Size in 2025 (Value)
US$ 37,710 million
Market Forecast in 2031(Value)
US$ 58,200 million
CAGR
7.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Plasma Fractionation Technology market size was US$ 35330 million in 2024 and is forecast to a readjusted size of US$ 58200 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation Technology. In this report, we mainly study the Plasma Fractionation Technology products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.

Market Drivers:

Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the Plasma Fractionation Technology market.

Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the Plasma Fractionation Technologyation market.

Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for Plasma Fractionation Technology to produce these therapies.

Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.

Market Challenges:

High Costs of Plasma-Derived Products: The complex and time-consuming process of Plasma Fractionation Technologyation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.

Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.

Stringent Regulatory Framework: Plasma Fractionation Technologyation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.

Complex Manufacturing Process: The Plasma Fractionation Technologyation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.

The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.

The classification of Plasma Fractionation Technology includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Plasma Fractionation Technology market.

North America is the largest consumption place, with a revenue market share nearly 40 % in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Plasma Fractionation Technology.

The global Plasma Fractionation Technology market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • RAAS
  • CBPO
  • Hualan Bio
  • Tiantan Bio
  • Shuanglin Bio
  • Boya Bio
  • Yuanda Shuyang
  • Weiguang Bio
  • Nanyue Bio
  • KM Biologics

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Immune Globulin
  • Coagulation Factor
  • Albumin
  • Other

Segment by Application

  • Hospital
  • Retail Pharmacy
  • Other

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

marn_i1

Chapter 2: Quantitative analysis of Plasma Fractionation Technology market size and growth potential at global, regional, and country levels.

marn_i1

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

marn_i1

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Coagulation Factor in China).

marn_i1

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Retail Pharmacy in India).

marn_i1

Chapter 6: Regional revenue breakdown by company, type, application and customer.

marn_i1

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

marn_i1

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Plasma Fractionation Technology value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Immune Globulin

1.2.3 Coagulation Factor

1.2.4 Albumin

1.2.5 Other

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Global Growth Trends

2.1 Global Plasma Fractionation Technology Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Plasma Fractionation Technology Revenue Market Share by Region (2020-2025)

2.4 Global Plasma Fractionation Technology Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Plasma Fractionation Technology Market Size and Prospective (2020-2031)

2.5.2 Europe Plasma Fractionation Technology Market Size and Prospective (2020-2031)

2.5.3 Asia-Pacific Plasma Fractionation Technology Market Size and Prospective (2020-2031)

2.5.4 Latin America Plasma Fractionation Technology Market Size and Prospective (2020-2031)

2.5.5 Middle East & Africa Plasma Fractionation Technology Market Size and Prospective (2020-2031)

muLu

3 Breakdown Data by Type

3.1 Global Plasma Fractionation Technology Historic Market Size by Type (2020-2025)

3.2 Global Plasma Fractionation Technology Forecasted Market Size by Type (2026-2031)

3.3 Different Types Plasma Fractionation Technology Representative Players

muLu

4 Breakdown Data by Application

4.1 Global Plasma Fractionation Technology Historic Market Size by Application (2020-2025)

4.2 Global Plasma Fractionation Technology Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in Plasma Fractionation Technology Application

muLu

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Plasma Fractionation Technology Players by Revenue (2020-2025)

5.1.2 Global Plasma Fractionation Technology Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Plasma Fractionation Technology Revenue

5.4 Global Plasma Fractionation Technology Market Concentration Analysis

5.4.1 Global Plasma Fractionation Technology Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Plasma Fractionation Technology Revenue in 2024

5.5 Global Key Players of Plasma Fractionation Technology Head office and Area Served

5.6 Global Key Players of Plasma Fractionation Technology, Product and Application

5.7 Global Key Players of Plasma Fractionation Technology, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

muLu

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Plasma Fractionation Technology Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Plasma Fractionation Technology Market Size by Type (2020-2025)

6.1.2.2 North America Plasma Fractionation Technology Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America Plasma Fractionation Technology Market Size by Application (2020-2025)

6.1.3.2 North America Plasma Fractionation Technology Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Plasma Fractionation Technology Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Plasma Fractionation Technology Market Size by Type (2020-2025)

6.2.2.2 Europe Plasma Fractionation Technology Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Plasma Fractionation Technology Market Size by Application (2020-2025)

6.2.3.2 Europe Plasma Fractionation Technology Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 Asia-Pacific Market: Players, Segments and Downstream

6.3.1 Asia-Pacific Plasma Fractionation Technology Revenue by Company (2020-2025)

6.3.2 Asia-Pacific Market Size by Type

6.3.2.1 Asia-Pacific Plasma Fractionation Technology Market Size by Type (2020-2025)

6.3.2.2 Asia-Pacific Plasma Fractionation Technology Market Share by Type (2020-2025)

6.3.3 Asia-Pacific Market Size by Application

6.3.3.1 Asia-Pacific Plasma Fractionation Technology Market Size by Application (2020-2025)

6.3.3.2 Asia-Pacific Plasma Fractionation Technology Market Share by Application (2020-2025)

6.3.4 Asia-Pacific Market Trend and Opportunities

6.4 Latin America Market: Players, Segments and Downstream

6.4.1 Latin America Plasma Fractionation Technology Revenue by Company (2020-2025)

6.4.2 Latin America Market Size by Type

6.4.2.1 Latin America Plasma Fractionation Technology Market Size by Type (2020-2025)

6.4.2.2 Latin America Plasma Fractionation Technology Market Share by Type (2020-2025)

6.4.3 Latin America Market Size by Application

6.4.3.1 Latin America Plasma Fractionation Technology Market Size by Application (2020-2025)

6.4.3.2 Latin America Plasma Fractionation Technology Market Share by Application (2020-2025)

6.4.4 Latin America Market Trend and Opportunities

6.5 Middle East & Africa Market: Players, Segments and Downstream

6.5.1 Middle East & Africa Plasma Fractionation Technology Revenue by Company (2020-2025)

6.5.2 Middle East & Africa Market Size by Type

6.5.2.1 Middle East & Africa Plasma Fractionation Technology Market Size by Type (2020-2025)

6.5.2.2 Middle East & Africa Plasma Fractionation Technology Market Share by Type (2020-2025)

6.5.3 Middle East & Africa Market Size by Application

6.5.3.1 Middle East & Africa Plasma Fractionation Technology Market Size by Application (2020-2025)

6.5.3.2 Middle East & Africa Plasma Fractionation Technology Market Share by Application (2020-2025)

6.5.4 Middle East & Africa Market Trend and Opportunities

muLu

7 Key Players Profiles

7.1 Takeda

7.1.1 Takeda Company Details

7.1.2 Takeda Business Overview

7.1.3 Takeda Plasma Fractionation Technology Introduction

7.1.4 Takeda Revenue in Plasma Fractionation Technology Business (2020-2025)

7.1.5 Takeda Recent Development

7.2 CSL

7.2.1 CSL Company Details

7.2.2 CSL Business Overview

7.2.3 CSL Plasma Fractionation Technology Introduction

7.2.4 CSL Revenue in Plasma Fractionation Technology Business (2020-2025)

7.2.5 CSL Recent Development

7.3 Grifols

7.3.1 Grifols Company Details

7.3.2 Grifols Business Overview

7.3.3 Grifols Plasma Fractionation Technology Introduction

7.3.4 Grifols Revenue in Plasma Fractionation Technology Business (2020-2025)

7.3.5 Grifols Recent Development

7.4 Octapharma

7.4.1 Octapharma Company Details

7.4.2 Octapharma Business Overview

7.4.3 Octapharma Plasma Fractionation Technology Introduction

7.4.4 Octapharma Revenue in Plasma Fractionation Technology Business (2020-2025)

7.4.5 Octapharma Recent Development

7.5 Kedrion

7.5.1 Kedrion Company Details

7.5.2 Kedrion Business Overview

7.5.3 Kedrion Plasma Fractionation Technology Introduction

7.5.4 Kedrion Revenue in Plasma Fractionation Technology Business (2020-2025)

7.5.5 Kedrion Recent Development

7.6 LFB Group

7.6.1 LFB Group Company Details

7.6.2 LFB Group Business Overview

7.6.3 LFB Group Plasma Fractionation Technology Introduction

7.6.4 LFB Group Revenue in Plasma Fractionation Technology Business (2020-2025)

7.6.5 LFB Group Recent Development

7.7 Biotest

7.7.1 Biotest Company Details

7.7.2 Biotest Business Overview

7.7.3 Biotest Plasma Fractionation Technology Introduction

7.7.4 Biotest Revenue in Plasma Fractionation Technology Business (2020-2025)

7.7.5 Biotest Recent Development

7.8 BPL

7.8.1 BPL Company Details

7.8.2 BPL Business Overview

7.8.3 BPL Plasma Fractionation Technology Introduction

7.8.4 BPL Revenue in Plasma Fractionation Technology Business (2020-2025)

7.8.5 BPL Recent Development

7.9 RAAS

7.9.1 RAAS Company Details

7.9.2 RAAS Business Overview

7.9.3 RAAS Plasma Fractionation Technology Introduction

7.9.4 RAAS Revenue in Plasma Fractionation Technology Business (2020-2025)

7.9.5 RAAS Recent Development

7.10 CBPO

7.10.1 CBPO Company Details

7.10.2 CBPO Business Overview

7.10.3 CBPO Plasma Fractionation Technology Introduction

7.10.4 CBPO Revenue in Plasma Fractionation Technology Business (2020-2025)

7.10.5 CBPO Recent Development

7.11 Hualan Bio

7.11.1 Hualan Bio Company Details

7.11.2 Hualan Bio Business Overview

7.11.3 Hualan Bio Plasma Fractionation Technology Introduction

7.11.4 Hualan Bio Revenue in Plasma Fractionation Technology Business (2020-2025)

7.11.5 Hualan Bio Recent Development

7.12 Tiantan Bio

7.12.1 Tiantan Bio Company Details

7.12.2 Tiantan Bio Business Overview

7.12.3 Tiantan Bio Plasma Fractionation Technology Introduction

7.12.4 Tiantan Bio Revenue in Plasma Fractionation Technology Business (2020-2025)

7.12.5 Tiantan Bio Recent Development

7.13 Shuanglin Bio

7.13.1 Shuanglin Bio Company Details

7.13.2 Shuanglin Bio Business Overview

7.13.3 Shuanglin Bio Plasma Fractionation Technology Introduction

7.13.4 Shuanglin Bio Revenue in Plasma Fractionation Technology Business (2020-2025)

7.13.5 Shuanglin Bio Recent Development

7.14 Boya Bio

7.14.1 Boya Bio Company Details

7.14.2 Boya Bio Business Overview

7.14.3 Boya Bio Plasma Fractionation Technology Introduction

7.14.4 Boya Bio Revenue in Plasma Fractionation Technology Business (2020-2025)

7.14.5 Boya Bio Recent Development

7.15 Yuanda Shuyang

7.15.1 Yuanda Shuyang Company Details

7.15.2 Yuanda Shuyang Business Overview

7.15.3 Yuanda Shuyang Plasma Fractionation Technology Introduction

7.15.4 Yuanda Shuyang Revenue in Plasma Fractionation Technology Business (2020-2025)

7.15.5 Yuanda Shuyang Recent Development

7.16 Weiguang Bio

7.16.1 Weiguang Bio Company Details

7.16.2 Weiguang Bio Business Overview

7.16.3 Weiguang Bio Plasma Fractionation Technology Introduction

7.16.4 Weiguang Bio Revenue in Plasma Fractionation Technology Business (2020-2025)

7.16.5 Weiguang Bio Recent Development

7.17 Nanyue Bio

7.17.1 Nanyue Bio Company Details

7.17.2 Nanyue Bio Business Overview

7.17.3 Nanyue Bio Plasma Fractionation Technology Introduction

7.17.4 Nanyue Bio Revenue in Plasma Fractionation Technology Business (2020-2025)

7.17.5 Nanyue Bio Recent Development

7.18 KM Biologics

7.18.1 KM Biologics Company Details

7.18.2 KM Biologics Business Overview

7.18.3 KM Biologics Plasma Fractionation Technology Introduction

7.18.4 KM Biologics Revenue in Plasma Fractionation Technology Business (2020-2025)

7.18.5 KM Biologics Recent Development

muLu

8 Plasma Fractionation Technology Market Dynamics

8.1 Plasma Fractionation Technology Industry Trends

8.2 Plasma Fractionation Technology Market Drivers

8.3 Plasma Fractionation Technology Market Challenges

8.4 Plasma Fractionation Technology Market Restraints

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Plasma Fractionation Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Plasma Fractionation Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Plasma Fractionation Technology Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Plasma Fractionation Technology Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Plasma Fractionation Technology Revenue Share by Region (2020-2025)
Table 6. Global Plasma Fractionation Technology Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Plasma Fractionation Technology Revenue Share Forecast by Region (2026-2031)
Table 8. Global Plasma Fractionation Technology Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Plasma Fractionation Technology Revenue Market Share by Type (2020-2025)
Table 10. Global Plasma Fractionation Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Plasma Fractionation Technology Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Plasma Fractionation Technology Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Plasma Fractionation Technology Revenue Market Share by Application (2020-2025)
Table 15. Global Plasma Fractionation Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Plasma Fractionation Technology Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Plasma Fractionation Technology Application
Table 18. Global Plasma Fractionation Technology Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Plasma Fractionation Technology Market Share by Players (2020-2025)
Table 20. Global Top Plasma Fractionation Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Fractionation Technology as of 2024)
Table 21. Ranking of Global Top Plasma Fractionation Technology Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Plasma Fractionation Technology Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Plasma Fractionation Technology, Headquarters and Area Served
Table 24. Global Key Players of Plasma Fractionation Technology, Product and Application
Table 25. Global Key Players of Plasma Fractionation Technology, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Plasma Fractionation Technology Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Plasma Fractionation Technology Revenue Market Share by Company (2020-2025)
Table 29. North America Plasma Fractionation Technology Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Plasma Fractionation Technology Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Plasma Fractionation Technology Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Plasma Fractionation Technology Revenue Market Share by Company (2020-2025)
Table 33. Europe Plasma Fractionation Technology Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Plasma Fractionation Technology Market Size by Application (2020-2025) & (US$ Million)
Table 35. Asia-Pacific Plasma Fractionation Technology Revenue by Company (2020-2025) & (US$ Million)
Table 36. Asia-Pacific Plasma Fractionation Technology Revenue Market Share by Company (2020-2025)
Table 37. Asia-Pacific Plasma Fractionation Technology Market Size by Type (2020-2025) & (US$ Million)
Table 38. Asia-Pacific Plasma Fractionation Technology Market Size by Application (2020-2025) & (US$ Million)
Table 39. Latin America Plasma Fractionation Technology Revenue by Company (2020-2025) & (US$ Million)
Table 40. Latin America Plasma Fractionation Technology Revenue Market Share by Company (2020-2025)
Table 41. Latin America Plasma Fractionation Technology Market Size by Type (2020-2025) & (US$ Million)
Table 42. Latin America Plasma Fractionation Technology Market Size by Application (2020-2025) & (US$ Million)
Table 43. Middle East & Africa Plasma Fractionation Technology Revenue by Company (2020-2025) & (US$ Million)
Table 44. Middle East & Africa Plasma Fractionation Technology Revenue Market Share by Company (2020-2025)
Table 45. Middle East & Africa Plasma Fractionation Technology Market Size by Type (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Plasma Fractionation Technology Market Size by Application (2020-2025) & (US$ Million)
Table 47. Takeda Company Details
Table 48. Takeda Business Overview
Table 49. Takeda Plasma Fractionation Technology Product
Table 50. Takeda Revenue in Plasma Fractionation Technology Business (2020-2025) & (US$ Million)
Table 51. Takeda Recent Development
Table 52. CSL Company Details
Table 53. CSL Business Overview
Table 54. CSL Plasma Fractionation Technology Product
Table 55. CSL Revenue in Plasma Fractionation Technology Business (2020-2025) & (US$ Million)
Table 56. CSL Recent Development
Table 57. Grifols Company Details
Table 58. Grifols Business Overview
Table 59. Grifols Plasma Fractionation Technology Product
Table 60. Grifols Revenue in Plasma Fractionation Technology Business (2020-2025) & (US$ Million)
Table 61. Grifols Recent Development
Table 62. Octapharma Company Details
Table 63. Octapharma Business Overview
Table 64. Octapharma Plasma Fractionation Technology Product
Table 65. Octapharma Revenue in Plasma Fractionation Technology Business (2020-2025) & (US$ Million)
Table 66. Octapharma Recent Development
Table 67. Kedrion Company Details
Table 68. Kedrion Business Overview
Table 69. Kedrion Plasma Fractionation Technology Product
Table 70. Kedrion Revenue in Plasma Fractionation Technology Business (2020-2025) & (US$ Million)
Table 71. Kedrion Recent Development
Table 72. LFB Group Company Details
Table 73. LFB Group Business Overview
Table 74. LFB Group Plasma Fractionation Technology Product
Table 75. LFB Group Revenue in Plasma Fractionation Technology Business (2020-2025) & (US$ Million)
Table 76. LFB Group Recent Development
Table 77. Biotest Company Details
Table 78. Biotest Business Overview
Table 79. Biotest Plasma Fractionation Technology Product
Table 80. Biotest Revenue in Plasma Fractionation Technology Business (2020-2025) & (US$ Million)
Table 81. Biotest Recent Development
Table 82. BPL Company Details
Table 83. BPL Business Overview
Table 84. BPL Plasma Fractionation Technology Product
Table 85. BPL Revenue in Plasma Fractionation Technology Business (2020-2025) & (US$ Million)
Table 86. BPL Recent Development
Table 87. RAAS Company Details
Table 88. RAAS Business Overview
Table 89. RAAS Plasma Fractionation Technology Product
Table 90. RAAS Revenue in Plasma Fractionation Technology Business (2020-2025) & (US$ Million)
Table 91. RAAS Recent Development
Table 92. CBPO Company Details
Table 93. CBPO Business Overview
Table 94. CBPO Plasma Fractionation Technology Product
Table 95. CBPO Revenue in Plasma Fractionation Technology Business (2020-2025) & (US$ Million)
Table 96. CBPO Recent Development
Table 97. Hualan Bio Company Details
Table 98. Hualan Bio Business Overview
Table 99. Hualan Bio Plasma Fractionation Technology Product
Table 100. Hualan Bio Revenue in Plasma Fractionation Technology Business (2020-2025) & (US$ Million)
Table 101. Hualan Bio Recent Development
Table 102. Tiantan Bio Company Details
Table 103. Tiantan Bio Business Overview
Table 104. Tiantan Bio Plasma Fractionation Technology Product
Table 105. Tiantan Bio Revenue in Plasma Fractionation Technology Business (2020-2025) & (US$ Million)
Table 106. Tiantan Bio Recent Development
Table 107. Shuanglin Bio Company Details
Table 108. Shuanglin Bio Business Overview
Table 109. Shuanglin Bio Plasma Fractionation Technology Product
Table 110. Shuanglin Bio Revenue in Plasma Fractionation Technology Business (2020-2025) & (US$ Million)
Table 111. Shuanglin Bio Recent Development
Table 112. Boya Bio Company Details
Table 113. Boya Bio Business Overview
Table 114. Boya Bio Plasma Fractionation Technology Product
Table 115. Boya Bio Revenue in Plasma Fractionation Technology Business (2020-2025) & (US$ Million)
Table 116. Boya Bio Recent Development
Table 117. Yuanda Shuyang Company Details
Table 118. Yuanda Shuyang Business Overview
Table 119. Yuanda Shuyang Plasma Fractionation Technology Product
Table 120. Yuanda Shuyang Revenue in Plasma Fractionation Technology Business (2020-2025) & (US$ Million)
Table 121. Yuanda Shuyang Recent Development
Table 122. Weiguang Bio Company Details
Table 123. Weiguang Bio Business Overview
Table 124. Weiguang Bio Plasma Fractionation Technology Product
Table 125. Weiguang Bio Revenue in Plasma Fractionation Technology Business (2020-2025) & (US$ Million)
Table 126. Weiguang Bio Recent Development
Table 127. Nanyue Bio Company Details
Table 128. Nanyue Bio Business Overview
Table 129. Nanyue Bio Plasma Fractionation Technology Product
Table 130. Nanyue Bio Revenue in Plasma Fractionation Technology Business (2020-2025) & (US$ Million)
Table 131. Nanyue Bio Recent Development
Table 132. KM Biologics Company Details
Table 133. KM Biologics Business Overview
Table 134. KM Biologics Plasma Fractionation Technology Product
Table 135. KM Biologics Revenue in Plasma Fractionation Technology Business (2020-2025) & (US$ Million)
Table 136. KM Biologics Recent Development
Table 137. Plasma Fractionation Technology Market Trends
Table 138. Plasma Fractionation Technology Market Drivers
Table 139. Plasma Fractionation Technology Market Challenges
Table 140. Plasma Fractionation Technology Market Restraints
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Plasma Fractionation Technology Product Picture
Figure 2. Global Plasma Fractionation Technology Market Share by Type: 2024 VS 2031
Figure 3. Immune Globulin Features
Figure 4. Coagulation Factor Features
Figure 5. Albumin Features
Figure 6. Other Features
Figure 7. Global Plasma Fractionation Technology Market Share by Application: 2024 VS 2031
Figure 8. Hospital
Figure 9. Retail Pharmacy
Figure 10. Other
Figure 11. Plasma Fractionation Technology Report Years Considered
Figure 12. Global Plasma Fractionation Technology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Plasma Fractionation Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Plasma Fractionation Technology Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Plasma Fractionation Technology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Plasma Fractionation Technology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Asia-Pacific Plasma Fractionation Technology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Latin America Plasma Fractionation Technology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Middle East & Africa Plasma Fractionation Technology Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Global Plasma Fractionation Technology Market Share by Players in 2024
Figure 21. Global Top Plasma Fractionation Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Fractionation Technology as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Plasma Fractionation Technology Revenue in 2024
Figure 23. North America Plasma Fractionation Technology Market Share by Type (2020-2025)
Figure 24. North America Plasma Fractionation Technology Market Share by Application (2020-2025)
Figure 25. Europe Plasma Fractionation Technology Market Share by Type (2020-2025)
Figure 26. Europe Plasma Fractionation Technology Market Share by Application (2020-2025)
Figure 27. Asia-Pacific Plasma Fractionation Technology Market Share by Type (2020-2025)
Figure 28. Asia-Pacific Plasma Fractionation Technology Market Share by Application (2020-2025)
Figure 29. Latin America Plasma Fractionation Technology Market Share by Type (2020-2025)
Figure 30. Latin America Plasma Fractionation Technology Market Share by Application (2020-2025)
Figure 31. Middle East & Africa Plasma Fractionation Technology Market Share by Type (2020-2025)
Figure 32. Middle East & Africa Plasma Fractionation Technology Market Share by Application (2020-2025)
Figure 33. Takeda Revenue Growth Rate in Plasma Fractionation Technology Business (2020-2025)
Figure 34. CSL Revenue Growth Rate in Plasma Fractionation Technology Business (2020-2025)
Figure 35. Grifols Revenue Growth Rate in Plasma Fractionation Technology Business (2020-2025)
Figure 36. Octapharma Revenue Growth Rate in Plasma Fractionation Technology Business (2020-2025)
Figure 37. Kedrion Revenue Growth Rate in Plasma Fractionation Technology Business (2020-2025)
Figure 38. LFB Group Revenue Growth Rate in Plasma Fractionation Technology Business (2020-2025)
Figure 39. Biotest Revenue Growth Rate in Plasma Fractionation Technology Business (2020-2025)
Figure 40. BPL Revenue Growth Rate in Plasma Fractionation Technology Business (2020-2025)
Figure 41. RAAS Revenue Growth Rate in Plasma Fractionation Technology Business (2020-2025)
Figure 42. CBPO Revenue Growth Rate in Plasma Fractionation Technology Business (2020-2025)
Figure 43. Hualan Bio Revenue Growth Rate in Plasma Fractionation Technology Business (2020-2025)
Figure 44. Tiantan Bio Revenue Growth Rate in Plasma Fractionation Technology Business (2020-2025)
Figure 45. Shuanglin Bio Revenue Growth Rate in Plasma Fractionation Technology Business (2020-2025)
Figure 46. Boya Bio Revenue Growth Rate in Plasma Fractionation Technology Business (2020-2025)
Figure 47. Yuanda Shuyang Revenue Growth Rate in Plasma Fractionation Technology Business (2020-2025)
Figure 48. Weiguang Bio Revenue Growth Rate in Plasma Fractionation Technology Business (2020-2025)
Figure 49. Nanyue Bio Revenue Growth Rate in Plasma Fractionation Technology Business (2020-2025)
Figure 50. KM Biologics Revenue Growth Rate in Plasma Fractionation Technology Business (2020-2025)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share?zhanKai
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 7.5% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Plasma Fractionation Technology in 2031?shouQi
What was the global market size of Plasma Fractionation Technology in 2025?shouQi
Which companies rank high in the global Plasma Fractionation Technology market?shouQi
What is the annual compound growth rate of the global Plasma Fractionation Technology market size from 2025 to 2031?shouQi
den_biaoTiZhungShi

Related Reports

Global Plasma Fractionation Technology Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Service & Software

Published Date: 2025-11-17

Pages: 105 Pages

Report ld: 5479001

CHOOSE LICENSE TYPE
tip

USD 4250.00

tip

USD 6375.00

tip

USD 8500.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

SIMON LEE

+1-62 6295 2442

English,Chinese

Offline

HITESH

HITESH

+91-86 6998 6909

English, Hindi

Online

TANG XIN

TANG XIN

+81-90 3800 9273

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

YUJIE TIAN

+86-135-2215-3954

Chinese, English

Offline

DAMON

DAMON

+86-133 1872 9947

Chinese, English

Offline

General Email:
global@qyresearch.com

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now